WELLINGTON MANAGEMENT GROUP LLP - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$412,784
+26.9%
378,701
+166.7%
0.00%
Q2 2023$325,194
-11.7%
142,006
-6.3%
0.00%
Q1 2023$368,128
+23.6%
151,493
-2.8%
0.00%
Q4 2022$297,780
-20.4%
155,906
+0.2%
0.00%
Q3 2022$374,000
-7.4%
155,643
-28.3%
0.00%
Q2 2022$404,000
-11.0%
217,1970.0%0.00%
Q1 2022$454,000
-46.5%
217,197
+0.8%
0.00%
Q4 2021$849,000
-71.1%
215,541
-11.8%
0.00%
-100.0%
Q2 2018$2,934,000
+3.9%
244,516
-25.8%
0.00%0.0%
Q1 2018$2,823,000
-13.3%
329,4290.0%0.00%0.0%
Q4 2017$3,255,000
+125.9%
329,429
+181.0%
0.00%
Q3 2017$1,441,000
-64.1%
117,255
-58.1%
0.00%
-100.0%
Q1 2017$4,013,000
+15.2%
279,874
+11.1%
0.00%0.0%
Q4 2016$3,484,000
-23.4%
251,910
+0.0%
0.00%0.0%
Q3 2016$4,550,000
+32.6%
251,806
+5.3%
0.00%0.0%
Q2 2016$3,432,000239,1770.00%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$25,366,000100.00%
Artal Group S.A. 71,178,364$417,817,0007.38%
BVF INC/IL 8,394,000$49,273,0001.85%
Boothe Investment Group, Inc. 435,939$2,559,0001.49%
Campbell & CO Investment Adviser LLC 103,100$605,0000.37%
NEA Management Company, LLC 2,382,286$13,984,0000.31%
PINNACLE ASSOCIATES LTD 2,167,172$12,721,0000.24%
Eversept Partners, LP 410,593$2,410,1810.18%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$210,0000.12%
OCCUDO QUANTITATIVE STRATEGIES LP 66,299$389,0000.08%
View complete list of LEXICON PHARMACEUTICALS INC shareholders